Redvaxin Private Limited, a active private limited company, was established on 12 July 2020 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230DL2020PTC365992. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.28 M.
It upholds a compliant status. Its leadership includes Sushil Kumar (Additional Director), Aparna Rajput (Director), Rakesh Sharma (Director). Past directors included Uttam Shivaji Kale. It holds ₹2.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Su-21, Dda Building, Madam Bhika Cama Place Bhawan, 11 Bhikaji Cama Place, New Delhi, Delhi, 110066.
U24230DL2020PTC365992
365992
12 July 2020
₹0.50 M
₹0.28 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Redvaxin Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sushil Kumar | Additional Director | 16 Jun 2025 | Current |
| Aparna Rajput | Director | 12 Jul 2020 | Current |
| Rakesh Sharma | Director | 12 Jul 2020 | Current |
| Usha Rani | Additional Director | 16 Jun 2025 | Current |
| Amit Kumar Luthra | Additional Director | 16 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Redvaxin Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 119.59% increase. The company also saw a substantial improvement in profitability, with a 56.25% increase in profit. The company's net worth Soared by an impressive increase of 160.75%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Redvaxin's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2024 | Others | ₹2.00 Cr | Open |
Explore comprehensive loan charge details -
Redvaxin has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Redvaxin, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redvaxin's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sushil Kumar was appointed as a Additional Director was appointed as a Additional Director on 16 Jun 2025 & has been associated with this company since 5 months 19 days . was documented.
The activity Usha Rani was appointed as a Additional Director was appointed as a Additional Director on 16 Jun 2025 & has been associated with this company since 5 months 19 days . was completed.
Progress on Amit Kumar Luthra was appointed as a Additional Director was appointed as a Additional Director on 16 Jun 2025 & has been associated with this company since 5 months 19 days . was documented.
Progress on A charge with Others amounted to Rs. 20.00 M with Charge ID 101023477 was registered on 13 Dec 2024. was documented.
Redvaxin Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Redvaxin Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The CIN of Redvaxin Private Limited is U24230DL2020PTC365992.
Redvaxin Private Limited is headquartered at Su-21, Dda Building, Madam Bhika Cama Place Bhawan, 11 Bhikaji Cama Place, New Delhi, Delhi, 110066.
Redvaxin Private Limited was incorporated on 12 July 2020.
The current directors of Redvaxin Private Limited are
The primary industry of Redvaxin Private Limited is Trade.
Redvaxin Private Limited is unlisted.
The authorized capital of Redvaxin Private Limited is ₹0.50 M, and the paid-up capital is ₹0.28 M.
The compliance status of Redvaxin Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX